Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Shares Issued (2022 - 2025)

Historic Shares Issued for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q1 2025 value amounting to $91000.0.

  • Orchestra BioMed Holdings' Shares Issued rose 40555.56% to $91000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $91000.0, marking a year-over-year decrease of 9940.08%. This contributed to the annual value of $15.0 million for FY2024, which is 640865.8% up from last year.
  • Orchestra BioMed Holdings' Shares Issued amounted to $91000.0 in Q1 2025, which was up 40555.56% from $14.8 million recorded in Q3 2024.
  • Orchestra BioMed Holdings' 5-year Shares Issued high stood at $14.8 million for Q3 2024, and its period low was $4000.0 during Q3 2022.
  • For the 4-year period, Orchestra BioMed Holdings' Shares Issued averaged around $1.4 million, with its median value being $64000.0 (2023).
  • As far as peak fluctuations go, Orchestra BioMed Holdings' Shares Issued crashed by 8648.65% in 2023, and later skyrocketed by 37105000.0% in 2024.
  • Orchestra BioMed Holdings' Shares Issued (Quarter) stood at $4000.0 in 2022, then soared by 3725.0% to $153000.0 in 2023, then surged by 9603.27% to $14.8 million in 2024, then tumbled by 99.39% to $91000.0 in 2025.
  • Its last three reported values are $91000.0 in Q1 2025, $14.8 million for Q3 2024, and $171000.0 during Q2 2024.